Prevalences of elevated ALT and elevated AST were greater in the present probands with than without NAFLD, although 56.3% of probands with NAFLD had neither elevated ALT nor elevated AST, and elevated ALT/AST was not significantly associated with NAFLD in a logistic regression. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.